C07H 17/075
Benzo[b]pyran-2-ones
C07H17/075 (Benzo[b]pyran-2-ones) appears on 79 US grants and 56 published applications in this corpus.
Search patents in C07H- Granted patents
- 79
- Published applications
- 56
- Assignees
- 60
- Inventors
- 197
- Latest grant
- 2 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 3 | 0 |
| 1980 | 5 | 0 |
| 1981 | 3 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 3 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 3 | 4 |
| 2003 | 6 | 3 |
| 2004 | 2 | 3 |
| 2005 | 3 | 0 |
| 2006 | 1 | 3 |
| 2007 | 0 | 1 |
| 2008 | 0 | 1 |
| 2009 | 3 | 1 |
| 2010 | 1 | 1 |
| 2011 | 0 | 2 |
| 2012 | 0 | 3 |
| 2013 | 3 | 3 |
| 2014 | 2 | 8 |
| 2015 | 3 | 2 |
| 2016 | 4 | 1 |
| 2017 | 2 | 6 |
| 2018 | 4 | 2 |
| 2019 | 6 | 0 |
| 2020 | 0 | 1 |
| 2021 | 1 | 2 |
| 2022 | 1 | 3 |
| 2023 | 1 | 1 |
| 2024 | 1 | 2 |
| 2025 | 2 | 0 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- 8-fluoro-4-alkylumbelliferyl α-D-glucopyranoside, biological sterilization indicator including the same and its use in a method of determining efficacy of a sterilization process2 Dec 2025US 12,486,301 B2Solventum Intellectual Properties Company
- Compounds and methods for treating cancer4 Mar 2025US RE50,319 E1Dana-Farber Cancer Institute, Inc.
- Fluorinated 4′-alkylumbelliferyl a-D-glucopyranosides, biological sterilization indicators including the same and methods of using the same22 Oct 2024US 12,123,048 B2Solventum Intellectual Property Company
- Aminocoumarin compounds and methods of their use1 Aug 2023US 11,713,335 B2President and Fellows of Harvard College
- Compounds and methods for treating cancer18 Jan 2022US 11,224,608 B2Dana-Farber Cancer Institute, Inc.
- Helicase inhibitors8 Oct 2026US 2026/0308196 A1H. Lee Moffitt Cancer Center and Research Institute, Inc.
- N-derivatized sialic acids and related sialosides20 Aug 2026US 2026/0242405 A1The Regents of the University of California
- 8-fluoro-4-alkylumbelliferyl alpha-d-glucopyranoside, biological sterilization indicator including the same and its use in a method of determining efficacy of a sterilization process19 Mar 2026US 2026/0078141 A1Solventum Intellectual Properties Company
- Phenylcoumarins for treating inflammation5 Dec 2024US 2024/0398844 A1Ohio State Innovation Foundation
- Chlorinated 4'-alkylumbelliferyl alpha-d-glucopyranoside and method of assessing efficacy of a sterilization process including the same19 Sep 2024US 2024/0307577 A13M Innovative Properties Company
Most cited
By later US patents
- Novobiocin analogues as anticancer agents107US 7,608,594 B2University of Kansas · 2009
- Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders107US 7,622,451 B2University of Kansas · 2009
- Method of hydrolyzing an enzymatic substrate88US 8,394,641 B2Advanced Liquid Logic, Inc. · 2013
- Beta-galactosyl-umbelliferone-labeled hapten conjugates71US 4,404,366 AMiles Laboratories, Inc. · 1983
- Specific binding assay employing an enzyme-cleavable substrate as label66US 4,279,992 AMiles Laboratories, Inc. · 1981